ATE421877T1 - Verwendung von totarol zur behandlung von pruritus - Google Patents

Verwendung von totarol zur behandlung von pruritus

Info

Publication number
ATE421877T1
ATE421877T1 AT02798982T AT02798982T ATE421877T1 AT E421877 T1 ATE421877 T1 AT E421877T1 AT 02798982 T AT02798982 T AT 02798982T AT 02798982 T AT02798982 T AT 02798982T AT E421877 T1 ATE421877 T1 AT E421877T1
Authority
AT
Austria
Prior art keywords
totarol
treat pruritus
pruritus
treat
pruritis
Prior art date
Application number
AT02798982T
Other languages
English (en)
Inventor
Gerard Gendimenico
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Application granted granted Critical
Publication of ATE421877T1 publication Critical patent/ATE421877T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Liquid Crystal Substances (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Cosmetics (AREA)
AT02798982T 2001-09-17 2002-09-17 Verwendung von totarol zur behandlung von pruritus ATE421877T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32266201P 2001-09-17 2001-09-17

Publications (1)

Publication Number Publication Date
ATE421877T1 true ATE421877T1 (de) 2009-02-15

Family

ID=23255865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02798982T ATE421877T1 (de) 2001-09-17 2002-09-17 Verwendung von totarol zur behandlung von pruritus

Country Status (10)

Country Link
US (1) US6881756B2 (de)
EP (1) EP1435927B1 (de)
JP (1) JP2005507882A (de)
KR (1) KR20040035798A (de)
AT (1) ATE421877T1 (de)
BR (1) BR0212576A (de)
CA (1) CA2460326A1 (de)
DE (1) DE60231050D1 (de)
ES (1) ES2319271T3 (de)
WO (1) WO2003024436A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4934280B2 (ja) * 2005-02-07 2012-05-16 花王株式会社 シワ改善剤
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20080003190A1 (en) * 2006-07-03 2008-01-03 Wille John J Jr Antibacterial botanicals
DE102006042742A1 (de) * 2006-09-12 2008-03-27 Barnikol-Keuten, Doris, Dr. Nano-Vehikel für den transkutanen Transport, diese enthaltende Zubereitungen und deren Anwendung
US7554793B2 (en) * 2006-11-16 2009-06-30 Kemet Electronics Corporation Low temperature curable conductive adhesive and capacitors formed thereby
EP1925301A1 (de) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Verwendung von tricyclischen Diterpenen und deren Derivaten zur Behandlung oder Vorbeugung von entzündlichen - und/oder Gelenkerkrankungen
FR2920299B1 (fr) * 2007-08-31 2012-06-15 Oreal Utilisation cosmetique d'une association synergique d'un derive phenanthrenaol et de palmitate d'ascrobyle a titre d'agent antioxydant
US8535738B2 (en) * 2007-12-20 2013-09-17 Elc Management, Llc Methods and compositions for treating skin
US9687517B2 (en) 2007-12-20 2017-06-27 Elc Management Llc Methods and compositions for treating skin
EP2143703B1 (de) 2008-07-08 2011-05-18 Cognis IP Management GmbH Verfahren zur Herstellung von (+)-Totarol
JP5610681B2 (ja) * 2008-09-19 2014-10-22 株式会社ノエビア 中性脂肪蓄積抑制剤
FR2939685B1 (fr) * 2008-12-17 2012-04-27 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle et un compose phenantrenol.
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
EP3153161A1 (de) 2011-05-12 2017-04-12 B.R.A.I.N. Biotechnology Research And Information Network AG Kleinmolekulare trpa1-hemmer
WO2013115759A1 (en) * 2012-02-01 2013-08-08 Horvat Branimir L Topical medications for controlling epidermal symptoms
DE102013108870A1 (de) 2013-08-16 2015-02-19 Aimecs Gmbh Mittel zur Reinigung und zum Schutz von technischen Oberflächen
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
US11147777B1 (en) 2017-06-16 2021-10-19 Charlotte's Web, Inc. Methods and formulations for efficacious pain relief by transdermal delivery of cannabidiol
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898887A (en) 1984-12-20 1990-02-06 The Procter & Gamble Company Compounds and compositions having anti-inflammatory and analgesic activity
JP2700071B2 (ja) * 1988-06-10 1998-01-19 株式会社資生堂 抗菌剤及びそれを用いた皮膚外用剤、口腔用組成物
CA2268399C (en) 1996-10-31 2008-08-19 Harbor Branch Oceanographic Institution, Inc. Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
FR2783169B1 (fr) 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)

Also Published As

Publication number Publication date
BR0212576A (pt) 2004-10-13
EP1435927A2 (de) 2004-07-14
KR20040035798A (ko) 2004-04-29
WO2003024436A3 (en) 2003-10-30
DE60231050D1 (de) 2009-03-19
CA2460326A1 (en) 2003-03-27
US20030104016A1 (en) 2003-06-05
EP1435927B1 (de) 2009-01-28
ES2319271T3 (es) 2009-05-06
JP2005507882A (ja) 2005-03-24
US6881756B2 (en) 2005-04-19
WO2003024436A2 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
EP1545587A4 (de) Lactoferrin-zusammensetzungen und wundbehandlungsverfahren
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
DK1365762T3 (da) Fremgangsmåde til forögelse af leptinniveauer under anvendelse af nicotinsyreforbindelser
ATE459349T1 (de) Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen
ATE535245T1 (de) Verwendung von mehrfach ungesättigten ketonen zur behandlung der psoriasis
TW200513271A (en) Topical treatment of skin conditions
DE69902154D1 (de) Eisen-dextran verbindung zur verwendung als komponente in einer therapeutischen zusammensetzung zur behandlung oder prophylaxe von eisenmangel, sowie verfahren zur herstellung der eisen-dextran verbindung und ihre anwendung zur herstellung einer parenteral anwendbaren therapeutischen zubereitung.
DE60218227D1 (de) Topisches dapson zur behandlung von akne
TW200505473A (en) Compositions and methods for treatment of psoriasis
DE69734838D1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
WO2004103353A3 (en) Topical treatment of sebum related skin conditions
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE60334830D1 (de) Furin-hemmer zur behandlung von fibrose und narbenbildung
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ATE502636T1 (de) Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen
DE50200626D1 (de) Topische verwendung von ätherischen ölen zur behandlung von wundheilungsstörungen
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties